 Norman Friedman
Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Apnea, Obstructive | 43 | 2024 | 200 | 15.980 |
Why?
| | Tonsillectomy | 33 | 2024 | 75 | 15.080 |
Why?
| | Adenoidectomy | 24 | 2024 | 61 | 6.200 |
Why?
| | Sleep Apnea Syndromes | 11 | 2024 | 74 | 4.830 |
Why?
| | Down Syndrome | 11 | 2024 | 338 | 4.060 |
Why?
| | Polysomnography | 22 | 2023 | 139 | 3.520 |
Why?
| | Endoscopy | 7 | 2024 | 248 | 1.560 |
Why?
| | Child | 54 | 2024 | 18366 | 1.510 |
Why?
| | Pediatric Obesity | 4 | 2021 | 489 | 1.460 |
Why?
| | Otitis Media | 8 | 2023 | 143 | 1.210 |
Why?
| | Practice Patterns, Physicians' | 6 | 2023 | 1177 | 1.200 |
Why?
| | Sleep | 7 | 2023 | 632 | 1.170 |
Why?
| | Child, Preschool | 33 | 2024 | 9086 | 1.030 |
Why?
| | Parents | 5 | 2024 | 1191 | 0.940 |
Why?
| | Otolaryngology | 4 | 2020 | 70 | 0.910 |
Why?
| | Retrospective Studies | 20 | 2023 | 12544 | 0.860 |
Why?
| | Humans | 75 | 2024 | 114937 | 0.820 |
Why?
| | Perception | 2 | 2024 | 311 | 0.810 |
Why?
| | Larynx | 1 | 2022 | 47 | 0.790 |
Why?
| | Pediatrics | 4 | 2019 | 984 | 0.790 |
Why?
| | Posture | 2 | 2021 | 154 | 0.770 |
Why?
| | Neck | 1 | 2021 | 83 | 0.730 |
Why?
| | Abscess | 1 | 2021 | 72 | 0.720 |
Why?
| | Snoring | 3 | 2015 | 12 | 0.690 |
Why?
| | Infant | 21 | 2021 | 7937 | 0.660 |
Why?
| | Body Mass Index | 4 | 2021 | 1961 | 0.650 |
Why?
| | Cleft Lip | 1 | 2018 | 32 | 0.630 |
Why?
| | Cleft Palate | 1 | 2018 | 46 | 0.620 |
Why?
| | Obesity, Morbid | 1 | 2021 | 197 | 0.610 |
Why?
| | Tongue | 2 | 2015 | 67 | 0.600 |
Why?
| | Anesthesia | 3 | 2016 | 117 | 0.600 |
Why?
| | Airway Obstruction | 2 | 2021 | 168 | 0.580 |
Why?
| | Palatine Tonsil | 2 | 2015 | 32 | 0.570 |
Why?
| | Severity of Illness Index | 9 | 2021 | 2542 | 0.570 |
Why?
| | Body Weight | 1 | 2021 | 868 | 0.550 |
Why?
| | Continuous Positive Airway Pressure | 2 | 2016 | 51 | 0.530 |
Why?
| | Organizational Policy | 1 | 2016 | 68 | 0.520 |
Why?
| | Male | 33 | 2023 | 55663 | 0.490 |
Why?
| | Craniofacial Abnormalities | 1 | 2015 | 59 | 0.480 |
Why?
| | Patient Admission | 1 | 2016 | 175 | 0.470 |
Why?
| | Female | 34 | 2023 | 59581 | 0.470 |
Why?
| | Oxygen | 4 | 2023 | 853 | 0.460 |
Why?
| | Emergencies | 1 | 2015 | 146 | 0.460 |
Why?
| | Patient Outcome Assessment | 1 | 2015 | 122 | 0.450 |
Why?
| | Obesity | 7 | 2023 | 2514 | 0.440 |
Why?
| | Cross-Sectional Studies | 8 | 2023 | 4407 | 0.420 |
Why?
| | Professional Practice | 1 | 2013 | 62 | 0.410 |
Why?
| | Patient Compliance | 1 | 2016 | 526 | 0.400 |
Why?
| | Nasopharynx | 3 | 2022 | 63 | 0.400 |
Why?
| | Cysts | 2 | 2010 | 93 | 0.390 |
Why?
| | Postoperative Hemorrhage | 1 | 2012 | 75 | 0.390 |
Why?
| | Prospective Studies | 7 | 2023 | 6218 | 0.380 |
Why?
| | Lacrimal Duct Obstruction | 1 | 2010 | 4 | 0.370 |
Why?
| | Nasolacrimal Duct | 1 | 2010 | 7 | 0.370 |
Why?
| | Dacryocystorhinostomy | 1 | 2010 | 10 | 0.360 |
Why?
| | Fucosyltransferases | 2 | 2022 | 27 | 0.350 |
Why?
| | Microbiota | 5 | 2023 | 649 | 0.330 |
Why?
| | Practice Guidelines as Topic | 4 | 2019 | 1400 | 0.320 |
Why?
| | Asthma | 1 | 2021 | 2042 | 0.320 |
Why?
| | Hypoxia | 1 | 2015 | 960 | 0.320 |
Why?
| | Thinness | 2 | 2021 | 87 | 0.310 |
Why?
| | Adolescent | 14 | 2023 | 17829 | 0.300 |
Why?
| | Perioperative Care | 2 | 2021 | 126 | 0.290 |
Why?
| | Infant, Newborn | 8 | 2021 | 5035 | 0.270 |
Why?
| | Tonsillitis | 2 | 2019 | 7 | 0.270 |
Why?
| | Diagnostic Techniques, Otological | 1 | 2006 | 2 | 0.270 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 2 | 2010 | 34 | 0.260 |
Why?
| | Patient Selection | 4 | 2024 | 642 | 0.240 |
Why?
| | Shaken Baby Syndrome | 1 | 2004 | 5 | 0.240 |
Why?
| | Treatment Outcome | 9 | 2021 | 9105 | 0.240 |
Why?
| | Esophageal Perforation | 1 | 2004 | 11 | 0.230 |
Why?
| | Head Injuries, Closed | 1 | 2004 | 48 | 0.230 |
Why?
| | Electric Stimulation Therapy | 1 | 2024 | 56 | 0.220 |
Why?
| | Hypertrophy | 3 | 2015 | 111 | 0.220 |
Why?
| | Turner Syndrome | 1 | 2023 | 45 | 0.220 |
Why?
| | Olfaction Disorders | 1 | 2023 | 50 | 0.210 |
Why?
| | Respiration | 1 | 2024 | 180 | 0.210 |
Why?
| | Bronchoscopy | 2 | 2021 | 246 | 0.210 |
Why?
| | Postoperative Complications | 3 | 2018 | 2133 | 0.200 |
Why?
| | Disorders of Excessive Somnolence | 1 | 2022 | 25 | 0.200 |
Why?
| | Prader-Willi Syndrome | 1 | 2022 | 25 | 0.200 |
Why?
| | Narcolepsy | 1 | 2022 | 19 | 0.200 |
Why?
| | Preoperative Care | 3 | 2011 | 317 | 0.200 |
Why?
| | Postoperative Period | 2 | 2017 | 289 | 0.200 |
Why?
| | Haemophilus Infections | 1 | 2022 | 28 | 0.200 |
Why?
| | Tracheitis | 1 | 2001 | 3 | 0.190 |
Why?
| | Epiglottitis | 1 | 2001 | 4 | 0.190 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 12 | 0.190 |
Why?
| | Coccidioidomycosis | 1 | 2001 | 7 | 0.190 |
Why?
| | Fluconazole | 1 | 2001 | 16 | 0.190 |
Why?
| | Laryngeal Diseases | 1 | 2001 | 21 | 0.190 |
Why?
| | Fishes | 1 | 2001 | 81 | 0.190 |
Why?
| | Croup | 1 | 2001 | 22 | 0.190 |
Why?
| | Patient Readmission | 2 | 2017 | 608 | 0.190 |
Why?
| | Supine Position | 1 | 2021 | 33 | 0.180 |
Why?
| | Ear, Middle | 4 | 2023 | 89 | 0.180 |
Why?
| | Cytodiagnosis | 1 | 2000 | 29 | 0.180 |
Why?
| | Ciliary Motility Disorders | 1 | 2000 | 21 | 0.180 |
Why?
| | Drainage | 1 | 2021 | 151 | 0.180 |
Why?
| | Tertiary Care Centers | 2 | 2023 | 126 | 0.180 |
Why?
| | Plasminogen | 1 | 2020 | 33 | 0.180 |
Why?
| | Choanal Atresia | 1 | 2000 | 2 | 0.180 |
Why?
| | Foreign Bodies | 1 | 2001 | 99 | 0.180 |
Why?
| | Canada | 2 | 2023 | 322 | 0.170 |
Why?
| | Conscious Sedation | 1 | 2021 | 79 | 0.170 |
Why?
| | Nasal Mucosa | 1 | 2000 | 93 | 0.170 |
Why?
| | alpha-Macroglobulins | 1 | 2019 | 24 | 0.160 |
Why?
| | Child Abuse | 1 | 2004 | 450 | 0.160 |
Why?
| | Pharyngeal Diseases | 1 | 2019 | 12 | 0.160 |
Why?
| | Comorbidity | 2 | 2015 | 1458 | 0.160 |
Why?
| | Sleep Wake Disorders | 1 | 2022 | 232 | 0.160 |
Why?
| | Middle Ear Ventilation | 1 | 2018 | 12 | 0.160 |
Why?
| | Tympanic Membrane | 3 | 2006 | 20 | 0.160 |
Why?
| | Deoxyribonuclease I | 1 | 2018 | 35 | 0.160 |
Why?
| | Mutation, Missense | 1 | 2020 | 295 | 0.160 |
Why?
| | Symptom Assessment | 1 | 2019 | 118 | 0.160 |
Why?
| | Weight Gain | 1 | 2021 | 451 | 0.150 |
Why?
| | Equipment Failure | 1 | 2018 | 107 | 0.150 |
Why?
| | Hospitals, Pediatric | 2 | 2023 | 479 | 0.150 |
Why?
| | Surveys and Questionnaires | 6 | 2023 | 4635 | 0.150 |
Why?
| | Evoked Potentials, Auditory, Brain Stem | 1 | 2018 | 53 | 0.150 |
Why?
| | Tympanic Membrane Perforation | 1 | 1997 | 12 | 0.150 |
Why?
| | Peritonsillar Abscess | 1 | 1997 | 3 | 0.150 |
Why?
| | Case-Control Studies | 3 | 2015 | 3008 | 0.150 |
Why?
| | Pharynx | 2 | 2023 | 50 | 0.140 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 1997 | 83 | 0.140 |
Why?
| | Adult | 8 | 2024 | 30608 | 0.140 |
Why?
| | Overweight | 1 | 2021 | 472 | 0.140 |
Why?
| | Streptococcal Infections | 2 | 2005 | 127 | 0.140 |
Why?
| | Anti-Bacterial Agents | 3 | 2021 | 1477 | 0.140 |
Why?
| | Biopsy | 1 | 2000 | 1045 | 0.140 |
Why?
| | Down-Regulation | 1 | 2019 | 596 | 0.140 |
Why?
| | Regression Analysis | 1 | 2019 | 947 | 0.140 |
Why?
| | Sequence Analysis, DNA | 1 | 2019 | 729 | 0.130 |
Why?
| | Reproducibility of Results | 3 | 2023 | 2770 | 0.130 |
Why?
| | Stents | 1 | 2000 | 476 | 0.130 |
Why?
| | Age Factors | 2 | 2013 | 2891 | 0.130 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2023 | 486 | 0.130 |
Why?
| | Membrane Proteins | 1 | 2021 | 1022 | 0.130 |
Why?
| | Quality Improvement | 2 | 2021 | 954 | 0.120 |
Why?
| | Self Care | 1 | 2017 | 350 | 0.120 |
Why?
| | Tomography, X-Ray Computed | 2 | 2021 | 2326 | 0.120 |
Why?
| | Anesthetics | 1 | 2014 | 54 | 0.120 |
Why?
| | Pedigree | 3 | 2020 | 467 | 0.120 |
Why?
| | Age Distribution | 1 | 2015 | 340 | 0.110 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2015 | 129 | 0.110 |
Why?
| | Genetic Variation | 1 | 2018 | 876 | 0.110 |
Why?
| | Length of Stay | 1 | 2017 | 949 | 0.110 |
Why?
| | Gene Expression Profiling | 1 | 2019 | 1523 | 0.100 |
Why?
| | Turbinates | 1 | 2012 | 12 | 0.100 |
Why?
| | Mutation | 2 | 2021 | 3354 | 0.100 |
Why?
| | Pharyngitis | 1 | 2012 | 24 | 0.100 |
Why?
| | United States | 5 | 2023 | 12211 | 0.100 |
Why?
| | Guideline Adherence | 1 | 2016 | 490 | 0.100 |
Why?
| | Premature Birth | 1 | 2015 | 276 | 0.100 |
Why?
| | Cohort Studies | 1 | 2021 | 4903 | 0.100 |
Why?
| | Orthodontic Appliances | 1 | 2010 | 10 | 0.090 |
Why?
| | Follow-Up Studies | 4 | 2019 | 4427 | 0.090 |
Why?
| | Health Care Surveys | 1 | 2013 | 539 | 0.090 |
Why?
| | Nasal Obstruction | 1 | 2010 | 23 | 0.090 |
Why?
| | Oximetry | 1 | 2010 | 81 | 0.090 |
Why?
| | Internet | 1 | 2013 | 599 | 0.080 |
Why?
| | Consensus | 2 | 2021 | 534 | 0.080 |
Why?
| | Chinchilla | 2 | 2018 | 38 | 0.070 |
Why?
| | Respiration, Artificial | 1 | 2010 | 526 | 0.070 |
Why?
| | Animals | 7 | 2022 | 31839 | 0.070 |
Why?
| | Chronic Disease | 1 | 2012 | 1593 | 0.070 |
Why?
| | Postoperative Care | 1 | 2007 | 220 | 0.070 |
Why?
| | Incidence | 1 | 2012 | 2316 | 0.070 |
Why?
| | Acute Disease | 2 | 2006 | 915 | 0.060 |
Why?
| | Colorado | 1 | 2015 | 4091 | 0.060 |
Why?
| | Amoxicillin | 1 | 2005 | 20 | 0.060 |
Why?
| | Case Management | 1 | 2005 | 62 | 0.060 |
Why?
| | Mice | 4 | 2022 | 14936 | 0.060 |
Why?
| | Electrosurgery | 1 | 2004 | 43 | 0.060 |
Why?
| | Hypoglossal Nerve | 1 | 2024 | 8 | 0.060 |
Why?
| | Tertiary Healthcare | 1 | 2023 | 29 | 0.060 |
Why?
| | Palate, Soft | 1 | 2023 | 10 | 0.060 |
Why?
| | Nose Diseases | 1 | 2003 | 11 | 0.060 |
Why?
| | Nose | 1 | 2024 | 55 | 0.060 |
Why?
| | Otitis Media with Effusion | 1 | 2003 | 21 | 0.060 |
Why?
| | Blister | 1 | 2003 | 43 | 0.060 |
Why?
| | Fatal Outcome | 1 | 2004 | 285 | 0.050 |
Why?
| | Odorants | 1 | 2023 | 128 | 0.050 |
Why?
| | Smell | 1 | 2023 | 112 | 0.050 |
Why?
| | Single-Blind Method | 2 | 2018 | 258 | 0.050 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2003 | 102 | 0.050 |
Why?
| | Recurrence | 2 | 2005 | 937 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 2 | 2021 | 2102 | 0.050 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 48 | 0.050 |
Why?
| | Evidence-Based Medicine | 2 | 2019 | 675 | 0.050 |
Why?
| | Injections, Intravenous | 1 | 2001 | 201 | 0.050 |
Why?
| | Biopsy, Needle | 1 | 2001 | 183 | 0.050 |
Why?
| | Mice, Inbred C57BL | 2 | 2021 | 4719 | 0.050 |
Why?
| | Laryngoscopy | 1 | 2001 | 93 | 0.040 |
Why?
| | Delphi Technique | 1 | 2021 | 162 | 0.040 |
Why?
| | Costs and Cost Analysis | 1 | 2000 | 195 | 0.040 |
Why?
| | Philippines | 1 | 2019 | 50 | 0.040 |
Why?
| | United Kingdom | 1 | 2000 | 227 | 0.040 |
Why?
| | Pakistan | 1 | 2019 | 73 | 0.040 |
Why?
| | Finland | 1 | 2019 | 69 | 0.040 |
Why?
| | Risk Factors | 1 | 2012 | 8637 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 189 | 0.040 |
Why?
| | Radiography | 1 | 2001 | 819 | 0.040 |
Why?
| | Statistics, Nonparametric | 1 | 2019 | 387 | 0.040 |
Why?
| | COS Cells | 1 | 2018 | 175 | 0.040 |
Why?
| | Administration, Topical | 1 | 2018 | 139 | 0.040 |
Why?
| | ROC Curve | 1 | 2019 | 448 | 0.040 |
Why?
| | Sleep Medicine Specialty | 1 | 2017 | 9 | 0.040 |
Why?
| | Injections, Intralesional | 1 | 1997 | 32 | 0.040 |
Why?
| | Exome | 1 | 2018 | 201 | 0.040 |
Why?
| | Prevalence | 1 | 2023 | 2252 | 0.040 |
Why?
| | Academies and Institutes | 1 | 2017 | 44 | 0.040 |
Why?
| | Electrocoagulation | 1 | 1997 | 38 | 0.040 |
Why?
| | Ambulatory Surgical Procedures | 1 | 1997 | 48 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2019 | 390 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 593 | 0.030 |
Why?
| | Advisory Committees | 1 | 2017 | 208 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 728 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 641 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2019 | 1700 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2018 | 1233 | 0.030 |
Why?
| | Wound Healing | 1 | 1997 | 258 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 1801 | 0.030 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2014 | 174 | 0.030 |
Why?
| | Algorithms | 1 | 2000 | 1474 | 0.030 |
Why?
| | Survival Rate | 1 | 1997 | 1644 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1997 | 1856 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 1893 | 0.030 |
Why?
| | Cell Line | 1 | 2018 | 2640 | 0.030 |
Why?
| | Quality of Life | 1 | 2022 | 2359 | 0.020 |
Why?
| | Inflammation | 1 | 2021 | 2485 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 2324 | 0.020 |
Why?
| | Interdisciplinary Communication | 1 | 2011 | 185 | 0.020 |
Why?
| | Risk Assessment | 1 | 2019 | 2975 | 0.020 |
Why?
| | Orthodontic Appliances, Removable | 1 | 2009 | 1 | 0.020 |
Why?
| | Long-Term Care | 1 | 2009 | 77 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 1997 | 3549 | 0.020 |
Why?
| | Signal Transduction | 1 | 2019 | 4525 | 0.020 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2005 | 63 | 0.020 |
Why?
| | Texas | 1 | 2005 | 188 | 0.020 |
Why?
| | Patient Education as Topic | 1 | 2009 | 678 | 0.010 |
Why?
| | Young Adult | 1 | 2019 | 10478 | 0.010 |
Why?
| | Streptococcus pneumoniae | 1 | 2005 | 134 | 0.010 |
Why?
| | Earache | 1 | 2003 | 4 | 0.010 |
Why?
| | Analgesics | 1 | 2005 | 158 | 0.010 |
Why?
| | Personal Satisfaction | 1 | 2005 | 182 | 0.010 |
Why?
| | Pain, Postoperative | 1 | 2004 | 191 | 0.010 |
Why?
| | Fever | 1 | 2003 | 279 | 0.010 |
Why?
| | Recovery of Function | 1 | 2004 | 572 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 26806 | 0.010 |
Why?
| | Safety | 1 | 1997 | 297 | 0.010 |
Why?
| | Hospitalization | 1 | 1997 | 1754 | 0.000 |
Why?
|
|
Friedman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|